Allurion Technologies (ALURW) Long-Term Debt Issuances (2022 - 2025)

Name: Allurion Technologies (ALURW) Long-Term Debt Issuances (2022 - 2025) | Business Quant
Creator: Business Quant

Allurion Technologies posted quarterly Long-Term Debt Issuances of $49.1 million for Q1 2025, up 725.21% on a QoQ basis from $5.9 million in Q2 2023.

Allurion Technologies (ALURW) has 3 years of Long-Term Debt Issuances data on file, last reported at $49.1 million in Q1 2025.

For the quarter ending Q1 2025, Long-Term Debt Issuances changed N/A year-over-year to $49.1 million; the trailing twelve-month figure through Dec 2025 stood at $49.1 million (up 725.21% YoY), and the FY2025 full-year result was $49.1 million, up 2.29% from the prior year.
Long-Term Debt Issuances for Q1 2025 stood at $49.1 million, up from $5.9 million in the prior quarter.
Across five years, Long-Term Debt Issuances topped out at $49.1 million in Q1 2025 and bottomed at $5.9 million in Q2 2023.
The 3-year median for Long-Term Debt Issuances is $13.6 million (2023), against an average of $18.7 million.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	19.86 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	-
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	-
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	-
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	11.71 Mn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	1.15 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	-
10	Allurion Technologies	-	-	1.23 Mn	-

Download Data 🔒